Literature DB >> 20340028

Impact of acute myocardial ischemia reperfusion on the tissue and blood-borne renin-angiotensin system.

Shizu Oyamada1, Cesario Bianchi, Shinji Takai, Michael P Robich, Richard T Clements, Louis Chu, Frank W Sellke.   

Abstract

We examined the impact of acute myocardial ischemia followed by reperfusion (AMI-R) on local and circulating renin-angiotensin system (RAS) in a swine model. The mid left anterior descending artery (n = 6) was occluded for 1 h, followed by reperfusion for 2 h. Monastryl blue/triphenyl tetrazolium chloride staining identified the area-at-risk (AAR) and infarction. A second group of control animals underwent sham operations (C: n = 4). Myocardial expression of angiotensinogen (AGT), renin, chymase, angiotensin converting enzyme (ACE), angiotensin II (Ang II), Ang II type1 receptor (AT1R) and Ang II type 2 receptor (AT2R) in the AAR and the non-ischemic left ventricle (NLV) was assessed. Serum level of these proteins at baseline and at the end of reperfusion was also examined. Chymase (P < 0.05), ACE (P < 0.05), Ang II (P < 0.05), AT1R (P < 0.05) and AT2R (P < 0.05) expressions were found to be significantly higher in the AAR compared to the NLV and C whereas no significant differences were found for AGT (P = 0.58) and renin (P = 0.38). Serum concentration of ACE was significantly higher at the end of reperfusion than at baseline (P < 0.01), whereas no significant difference was found for chymase (P = 0.71), AGT (P = 0.57) and Ang II (P = 0.19). Immunohistochemistry of myocardial sections demonstrated significantly higher expression of ACE (P = 0.02), AT1R (P = 0.01), AT2R (P = 0.02) and Ang II (P < 0.01) in the AAR as compared to the NLV, whereas no significant difference was found for renin (P = 0.39). In conclusion, AMI-R resulted in significantly higher expression of specific cardiac RAS components in AAR compared to the NLV in the acute period.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20340028     DOI: 10.1007/s00395-010-0093-4

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  9 in total

Review 1.  Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?

Authors:  Vadim Tchaikovski; Gregory Y H Lip
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

2.  Mast cell derived carboxypeptidase A3 is decreased among patients with advanced coronary artery disease.

Authors:  Łukasz Lewicki; Janusz Siebert; Tomasz Koliński; Karolina Piekarska; Magdalena Reiwer-Gostomska; Radosław Targoński; Piotr Trzonkowski; Natalia Marek-Trzonkowska
Journal:  Cardiol J       Date:  2018-03-07       Impact factor: 2.737

3.  Elastase-2, an angiotensin II-generating enzyme, contributes to increased angiotensin II in resistance arteries of mice with myocardial infarction.

Authors:  Christiane Becari; Marcondes A B Silva; Marina T Durand; Cibele M Prado; Eduardo B Oliveira; Mauricio S Ribeiro; Helio C Salgado; Maria Cristina O Salgado; Rita C Tostes
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

4.  ROS and endothelial nitric oxide synthase (eNOS)-dependent trafficking of angiotensin II type 2 receptor begets neuronal NOS in cardiac myocytes.

Authors:  Ji Hyun Jang; Jung Nyeo Chun; Shigeo Godo; Guangyu Wu; Hiroaki Shimokawa; Chun Zi Jin; Ju Hong Jeon; Sung Joon Kim; Zhe Hu Jin; Yin Hua Zhang
Journal:  Basic Res Cardiol       Date:  2015-03-25       Impact factor: 17.165

Review 5.  Knocking out angiotensin II in the heart.

Authors:  Daniela Zablocki; Junichi Sadoshima
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

6.  Association of serum levels of AngII, KLK1, and ACE/KLK1 polymorphisms with acute myocardial infarction induced by coronary artery stenosis.

Authors:  Shu-hong Dai; Ji-fu Li; Jin-bo Feng; Rui-jian Li; Chuan-bao Li; Zhuo Li; Yun Zhang; Da-qing Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-06-21       Impact factor: 1.636

7.  Propionate alleviates myocardial ischemia-reperfusion injury aggravated by Angiotensin II dependent on caveolin-1/ACE2 axis through GPR41.

Authors:  Fan Deng; Liang-Qing Zhang; Han Wu; Yu Chen; Wen-Qian Yu; Rong-Hui Han; Yuan Han; Xiao-Qi Zhang; Qi-Shun Sun; Ze-Bin Lin; Yu Wang; Yong-Pan Liu; Jing-Yi Chen; Ke-Xuan Liu; Jing-Juan Hu
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

8.  Early ACEI/ARB use and in-hospital outcomes of acute myocardial infarction patients with systolic blood pressure <100 mmHg and undergoing percutaneous coronary intervention: Findings from the CCC-ACS project.

Authors:  Xuedong Zhao; Guanqi Zhao; Mengge Zhou; Ge Wang; Changsheng Ma; Sidney C Smith; Gregg C Fonarow; Louise Morgan; Bin Que; Hui Ai; Jing Liu; Dong Zhao; Shaoping Nie
Journal:  Front Cardiovasc Med       Date:  2022-09-29

9.  Molecular modeling study for inhibition mechanism of human chymase and its application in inhibitor design.

Authors:  Mahreen Arooj; Songmi Kim; Sugunadevi Sakkiah; Guang Ping Cao; Yuno Lee; Keun Woo Lee
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.